Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Quantification of ivermectin in veterinary products consumed off-label as a treatment for COVID-19

Wentzel et al., Pharmazie, doi:10.1691/ph.2024.4035
Dec 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020, now with p < 0.00000000001 from 105 studies, recognized in 23 countries.
No treatment is 100% effective. Protocols combine treatments.
5,300+ studies for 115 treatments. c19ivm.org
Analysis of 9 veterinary ivermectin products that were reportedly used off-label as a treatment for COVID-19. All tested products contained ivermectin within acceptable limits of their label claims. In terms of the ivermectin content, this study shows more reliable results than studies analyzing products intended for human use1-4, however use of veterinary ivermectin products in humans is not recommended due to the potential for dosing errors, untested administration regimens, and the presence of excipients and secondary actives that have not been evaluated for human safety.
Wentzel et al., 31 Dec 2024, peer-reviewed, 4 authors. Contact: frank.vanderkooy@nwu.ac.za.
This PaperIvermectinAll
Quantification of ivermectin in veterinary products consumed off-label as a treatment for COVID-19
C Wentzel, N Gernandt, M Gerber, Frank Van Der Kooy
doi:10.1691/ph.2024.4035
The COVID-19 pandemic caused global pandemonium, and due to an unprecedented global response, the popularity and use of (veterinary) ivermectin, amongst many other conceivable 'treatments' , experienced a meteoric rise. Ivermectin is a macrocyclic lactone compound belonging to the avermectin drug class and is a registered medicine in many countries, although the most common use is as veterinary medicine. In this study, a fast HPLC method was developed and validated for the quantification of ivermectin in veterinary products that were used off-label by a substantial number of people during COVID-19. Locally used veterinary products were collected as well as commercial products acquired and were tested using the newly developed method. The ivermectin content was compared to the products' label claims and it was found that all products tested contained ivermectin within acceptable limits. However, the use of veterinary products is strongly discouraged due to high dosages and administration regimens that were tested in animals and can lead to serious adverse events in humans. The presence of untested excipients and secondary actives, such as clorsulon, which can cause unknown (long-term) health impacts in humans, further adds credence to this warning.
References
Callaway, Cyranoski, Anti-parasite drugs sweep Nobel prize in medicine, Nature
Dourmishev, Dourmishev, Schwartz, Ivermectin: pharmacology and application in dermatology, Int J Dermatol
Fox, Ivermectin: uses and impact 20 years on, Curr Opin Infect Dis
Hiwa, Khulod, Optimization and validation of high-performance liquid chromatography using modified QuEChERS to determine anthelmintic drugs in mutton, BMC
Hoang, Temple, Correia, Clemons, Hendrickson, Characteristics of ivermectin toxicity in patients taking veterinary and human formulations for the prevention and treatment of COVID-19, Clin Toxicol
Ibrahim, Wang, Hollenbeck, Martinez, Fahmy et al., Development and validation of a stability-indicating UPLC-DAD method for the simultaneous determination of Ivermectin and Praziquantel in pharmaceutical tablets and dissolution media, AAPS PharmSciTech
Lorente, Voigt, Plessis, Balme, Marks et al., Ivermectin exposures reported to the Poisons Information Helpline in RSA during the COVID-19 pandemic, S Afr Med J
Martin, Robertson, Choudhary, Ivermectin: an anthelmintic, an insecticide, and much more, Trends Parasitol
Movahedi, Bragazzi, Ahamadi, Asgary, Mellado et al., Off-label drug use during the COVID-19 pandemic in Africa: topic modelling and sentiment analysis of ivermectin in South Africa and Nigeria as a case study, J R Soc Interface
Mudzunga, Act 36 of 1947
Mueller, Rosenkrantz, Bensignor, Karaś-Tęcza, Paterson et al., Diagnosis and treatment of demodicosis in dogs and cats: Clinical consensus guidelines of the World Association for Veterinary Dermatology, Vet Dermatol
Overholt, Chau, Mohan, Nepal, Ivermectin-Clorsulon overdose in attempting Coronavirus disease 2019 prophylaxis: A case report, Ann Intern Med Clin Cases
Romo, Poison control centers are fielding a surge of Ivermectin overdose calls
Van Eeden, Ivermectin: Price of cattle drug increases from R49 to R899! Farmer's Inside Track
Who, None
Who, The selection and use of essential medicines
Wimalasinghe, Zhao, Wang, Rustum, Development and validation of a stability-indicating reversed-phase high-performance liquid chromatography (RP-HPLC) method for identification, assay, and estimation of related substances of ivermectin drug substance, J. AOAC Int
DOI record: { "DOI": "10.1691/ph.2024.4035", "ISSN": "0031-7144", "URL": "https://doi.org/10.1691/ph.2024.4035", "author": [ { "family": "Wentzel", "given": "C." }, { "family": "Gernandt", "given": "N." }, { "family": "Gerber", "given": "M." }, { "family": "van der Kooy", "given": "F." } ], "container-title": "Pharmazie", "issue": "10/12", "issued": { "date-parts": [ [ 2024, 12 ] ] }, "language": "eng", "medium": "JD", "page": "216–219", "publisher": "AVOXA Mediengruppe Deutscher Apotheker GmbH", "publisher-place": "DE", "title": "Quantification of ivermectin in veterinary products consumed off-label as a treatment for COVID-19", "type": "article-journal", "volume": "79" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit